FRM
ALXN
Fox Run Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,925
| Closed | -$335K | – | 310 |
|
|
2020
Q3 | $335K | Sell |
2,925
-642
| -18% | -$73.5K | 0.84% | 26 |
|
|
2020
Q2 | $400K | Buy |
+3,567
| New | +$400K | 0.53% | 41 |
|
|
2020
Q1 | – | Sell |
-2,344
| Closed | -$254K | – | 422 |
|
|
2019
Q4 | $254K | Sell |
2,344
-4,690
| -67% | -$508K | 0.2% | 254 |
|
|
2019
Q3 | $689K | Buy |
7,034
+2,419
| +52% | +$237K | 0.63% | 9 |
|
|
2019
Q2 | $604K | Buy |
+4,615
| New | +$604K | 0.4% | 44 |
|
|
2019
Q1 | – | Sell |
-8,135
| Closed | -$792K | – | 766 |
|
|
2018
Q4 | $792K | Buy |
+8,135
| New | +$792K | 0.42% | 25 |
|
|
2018
Q2 | – | Sell |
-13,562
| Closed | -$1.51M | – | 992 |
|
|
2018
Q1 | $1.51M | Buy |
+13,562
| New | +$1.51M | 0.37% | 16 |
|
|
2017
Q4 | – | Sell |
-8,300
| Closed | -$1.16M | – | 961 |
|
|
2017
Q3 | $1.16M | Buy |
8,300
+4,800
| +137% | +$673K | 0.33% | 30 |
|
|
2017
Q2 | $426K | Buy |
+3,500
| New | +$426K | 0.15% | 280 |
|
|
2016
Q4 | – | Sell |
-2,600
| Closed | -$319K | – | 737 |
|
|
2016
Q3 | $319K | Buy |
+2,600
| New | +$319K | 0.19% | 234 |
|